Jeff Goldberg is currently a Scientific Advisor at Annexon Biosciences. Jeff has over 20 years of experience in the biotech/pharmaceutical industry, holding various leadership positions at major companies.
Jeff started their career as a Manufacturing Engineer at Genetics Institute/Wyeth. Jeff then transitioned into a commercial role as Associate Vice President, Project Head at sanofi-aventis. In this role, they were responsible for leading portfolio evaluations for development opportunities in multiple tumor types, partnering with regional and global teams to drive sales growth, and developing and executing life cycle management plans.
After 12 years at sanofi-aventis, Jeff became the Chief Operating Officer at Akcea Therapeutics, where they oversaw all business operations for the company. Jeff then took on the role of Vice President, Business Operations at Proteostasis before joining Annexon Biosciences as a Scientific Advisor.
Jeff Goldberg has a SM & MBA from the Massachusetts Institute of Technology in Chemical Engineering and Management, and a BS from Cornell University in Chemical Engineering.